Remedy Entertainment Signs Deal With Tencent For Its First Games-As-A-Service Title

Rem­e­dy, the stu­dio behind Alan Wake and Con­trol, are keep­ing them­selves real­ly busy. While the stu­dio is cur­rent­ly work­ing on Alan Wake 2, they’ve also announced a deal with Ten­cent for its upcom­ing free-to-play shoot­er Vanguard.

Rem­e­dy and Ten­cent announced this deal cov­ers “glob­al devel­op­ment, license, and dis­tri­b­u­tion” of the new IP. Not much is known about Van­guard, but Rem­e­dy says it’s a co-op PvE shoot­er that takes advan­tage of Rem­e­dy’s “nar­ra­tive exper­tise and action game­play” cre­at­ing an “immer­sive mul­ti­play­er experience.”

“The game is devel­oped with the Unre­al Engine for PC and con­sole plat­forms. Rem­e­dy will devel­op and pub­lish the game world­wide, exclud­ing select­ed Asian mar­kets, where Ten­cent will local­ize and pub­lish the game,” Rem­e­dy stat­ed in its announcement.

Van­guard is cur­rent­ly in the “proof-of-con­cept phase.” Rem­e­dy said the bud­get for the first year will be “in the range of a typ­i­cal Rem­e­dy AAA game budget.”

Devel­op­ment will be co-fund­ed by Rem­e­dy and Ten­cent, with Ten­cent cov­er­ing the costs of local­iz­ing Van­guard for Asian markets.

“Rem­e­dy and Ten­cent will be respon­si­ble for their own pub­lish­ing and game oper­at­ing costs in their respec­tive ter­ri­to­ries while shar­ing a por­tion of rev­enue to the oth­er par­ty after the recoup­ment of the devel­op­ment costs,” Rem­e­dy said.

Addi­tion­al­ly, Ten­cent has sold the glob­al rights to a mobile ver­sion of Van­guard to Ten­cent, which will cov­er the expens­es of devel­op­ing and pub­lish­ing the mobile edition.

Van­guard is Rem­e­dy’s first games-as-a-ser­vice title. Rem­e­dy CEO Tero Vir­ta­la said in a state­ment that it’s an excit­ing time for the company.

“Van­guard marks Rem­e­dy’s first entry into Games-as-a-Ser­vice busi­ness mod­el, exe­cut­ed by our top tier team of free-to-play experts. We are build­ing some­thing new and excit­ing for co-oper­a­tive mul­ti­play­er space, on top of Rem­e­dy’s strengths,” Vir­ta­la said. Expand­ing our capa­bil­i­ties to take on pub­lish­ing respon­si­bil­i­ties is the next step in the devel­op­ment of our com­pa­ny. We are excit­ed for this long-term part­ner­ship with Ten­cent and with con­fi­dence can say that it is an excel­lent fit in sup­port­ing Vanguard’s ambi­tious plans. Van­guard is a glob­al oppor­tu­ni­ty, and Ten­cent can sup­port Rem­e­dy inter­na­tion­al­ly, and lead the oper­a­tions in Asia and the mobile markets.”